INSPIRE MEDICAL SYSTEMS INC

NYSE: INSP (Inspire Medical Systems, Inc.)

Last update: 06 Jan, 4:45AM

94.76

2.49 (2.70%)

Previous Close 92.27
Open 93.87
Volume 1,258,537
Avg. Volume (3M) 1,555,072
Market Cap 2,802,462,208
Price / Earnings (TTM) 64.90
Price / Earnings (Forward) 44.25
Price / Sales 2.10
Price / Book 2.36
52 Weeks Range
70.77 (-25%) — 216.01 (127%)
Profit Margin 7.92%
Operating Margin (TTM) -0.74%
Diluted EPS (TTM) 2.19
Quarterly Revenue Growth (YOY) 22.70%
Quarterly Earnings Growth (YOY) 138.60%
Total Debt/Equity (MRQ) 5.27%
Current Ratio (MRQ) 9.01
Operating Cash Flow (TTM) 114.68 M
Levered Free Cash Flow (TTM) 42.41 M
Return on Assets (TTM) 4.40%
Return on Equity (TTM) 10.86%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Bearish
Medical Devices (Global) Mixed Bearish
Stock Inspire Medical Systems, Inc. Bearish Bearish

AIStockmoo Score

-1.6
Analyst Consensus -3.5
Insider Activity 0.0
Price Volatility -2.0
Technical Moving Averages 1.5
Technical Oscillators -4.0
Average -1.60

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
INSP 3 B - 64.90 2.36
PEN 13 B - 74.75 9.88
GMED 13 B - 31.14 2.85
GKOS 7 B - - 10.66
ITGR 3 B - 35.36 1.71
AORT 2 B - 178.67 4.12

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Sector Healthcare
Industry Medical Devices
Investment Style Small Growth
% Held by Insiders 1.11%
% Held by Institutions 119.04%
52 Weeks Range
70.77 (-25%) — 216.01 (127%)
Price Target Range
66.00 (-30%) — 175.00 (84%)
High 175.00 (Oppenheimer, 84.68%) Buy
Median 85.00 (-10.30%)
Low 66.00 (Jefferies, -30.35%) Hold
Average 89.73 (-5.31%)
Total 4 Buy, 7 Hold
Avg. Price @ Call 76.05
Firm Date Target Price Call Price @ Call
Stifel 05 Mar 2026 85.00 (-10.30%) Buy 64.51
Baird 12 Feb 2026 74.00 (-21.91%) Hold 59.65
Jefferies 12 Feb 2026 66.00 (-30.35%) Hold 59.65
Mizuho 12 Feb 2026 85.00 (-10.30%) Buy 59.65
17 Dec 2025 130.00 (37.19%) Buy 118.27
Piper Sandler 12 Feb 2026 85.00 (-10.30%) Buy 59.65
08 Dec 2025 165.00 (74.12%) Buy 143.99
RBC Capital 12 Feb 2026 68.00 (-28.24%) Hold 59.65
27 Jan 2026 90.00 (-5.02%) Hold 81.79
Truist Securities 12 Feb 2026 70.00 (-26.13%) Hold 59.65
08 Jan 2026 120.00 (26.64%) Buy 95.00
Wells Fargo 12 Feb 2026 70.00 (-26.13%) Hold 59.65
14 Jan 2026 145.00 (53.02%) Buy 93.05
UBS 23 Dec 2025 91.00 (-3.97%) Hold 94.98
JP Morgan 16 Dec 2025 118.00 (24.53%) Hold 115.51
Oppenheimer 08 Dec 2025 175.00 (84.68%) Buy 143.99
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
HERBERT TIMOTHY P. 59.53 59.53 67,148 3,997,320
KELLY JASON P 59.53 - 15,958 949,980
MANN MELISSA 59.53 - 15,958 949,980
PHILLIPS BRYAN K 59.53 59.53 26,022 1,549,090
RONDONI JOHN 59.53 59.53 17,623 1,049,097
WEATHERBY CARLTON 59.53 59.53 35,119 2,090,634
Aggregate Net Quantity 177,828
Aggregate Net Value ($) 10,586,101
Aggregate Avg. Buy ($) 59.53
Aggregate Avg. Sell ($) 59.53
Name Holder Date Type Quantity Price Value ($)
RONDONI JOHN Officer 20 Feb 2026 Disposed (-) 735 59.53 43,755
RONDONI JOHN Officer 20 Feb 2026 Acquired (+) 18,358 59.53 1,092,852
WEATHERBY CARLTON Officer 20 Feb 2026 Disposed (-) 672 59.53 40,004
WEATHERBY CARLTON Officer 20 Feb 2026 Acquired (+) 35,791 59.53 2,130,638
MANN MELISSA Officer 20 Feb 2026 Acquired (+) 15,958 59.53 949,980
KELLY JASON P Officer 20 Feb 2026 Acquired (+) 15,958 59.53 949,980
PHILLIPS BRYAN K Officer 20 Feb 2026 Disposed (-) 735 59.53 43,755
PHILLIPS BRYAN K Officer 20 Feb 2026 Acquired (+) 26,757 59.53 1,592,844
HERBERT TIMOTHY P. Officer 20 Feb 2026 Disposed (-) 4,010 59.53 238,715
HERBERT TIMOTHY P. Officer 20 Feb 2026 Acquired (+) 71,158 59.53 4,236,036
Date Type Details
12 Jan 2026 Announcement Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
07 Jan 2026 Announcement Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
05 Jan 2026 Announcement Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
30 Dec 2025 Announcement Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
29 Dec 2025 Announcement Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
29 Dec 2025 Announcement Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
26 Dec 2025 Announcement Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
23 Dec 2025 Announcement Shareholders SueWallSt in New Class Action Against Inspire Medical Systems, Inc. - Act Now
18 Dec 2025 Announcement Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
17 Dec 2025 Announcement Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
16 Dec 2025 Announcement New SueWallSt Podcast Covers Inspire Medical Systems, Inc. (INSP) Class Action
15 Dec 2025 Announcement Investors SueWallSt as Inspire Medical Systems, Inc. Faces Securities Fraud Allegations
15 Dec 2025 Announcement Tune Into the SueWallSt Podcast: Inspire Medical Systems, Inc. (INSP) Lawsuit Explained
12 Dec 2025 Announcement Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
08 Dec 2025 Announcement SueWallSt Podcast Explains Class Action Against Inspire Medical Systems, Inc. (INSP)
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria